Skip to content
Recall Observatory FDA recall evidence

Drug product

fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-2

D-0020-2024

September 21, 2023

Class II

Product summary

Firm
Central Admixture Pharmacy Services Inc
Event
Event 93103
Status
Terminated
Classification
Class II
Quantity
174, 5 mL syringes.
Official record key
drug-enforcement:D-0020-2024

Official wording

Reason: Lack of assurance of sterility:

Code information: Lot:17-275479, Exp. 10/4/2023; 17-275852, Exp. 10/11/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of assurance of sterility